The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Lack of a chemobrain effect for adjuvant FOLFOX chemotherapy in colon cancer patients: A pilot study.
Alberto Zaniboni
No relevant relationships to disclose
Federica Andreis
No relevant relationships to disclose
Marco Ferri
No relevant relationships to disclose
Maria Mazzocchi
No relevant relationships to disclose
Fausto Meriggi
No relevant relationships to disclose
Anna Rizzi
No relevant relationships to disclose
Luigina Rota
No relevant relationships to disclose
Brunella Di Biasi
No relevant relationships to disclose
Chiara Abeni
No relevant relationships to disclose
Claudio Codignola
No relevant relationships to disclose
Renzo Rozzini
No relevant relationships to disclose